Document complet  |  Dérouler chapitre  |  Etendre sommaire  |  Version HTML imprimable
Stability of Oral Oxytocics in Tropical Climates - Results of Simulation Studies on Oral Ergometrine, Oral Methylergometrine, Buccal Oxytocin and Buccal Desamino-Oxytocin - EDM Research Series No. 012
(1994; 52 pages) Voir le document au format PDF
Table des matières
Afficher le documentAbbreviations
Afficher le documentSummary
Ouvrir ce répertoire et afficher son contenuIntroduction
Ouvrir ce répertoire et afficher son contenuMaterials and methods
Ouvrir ce répertoire et afficher son contenuResults
Ouvrir ce répertoire et afficher son contenuDiscussion
Afficher le documentConclusions and recommendations
Afficher le documentReferences
Ouvrir ce répertoire et afficher son contenuAnnexes
 

References

1. Van Roosmalen J. Maternal health care in the South-western Highlands of Tanzania. Thesis, Leiden, The Netherlands, 1988.

2. Royston E, Armstrong S. Preventing maternal deaths. World Health Organization, Geneva, 1989.

3. Van Dongen PWJ, van Roosmalen J, de Boer CN, van Rooy J. Oxytocics for the prevention of postpartum haemorrhages, a review. Pharm Weekbl [Sci] 1991; 13(6):238-243.

4. Prendiville WJ, Harding JE, Elbourne DR, Chalmers I. The effects of routine oxytocic administration in the management of the third stage of labour: an overview of the evidence from controlled trials. Br J Obstet Gynaecol 1988; 95: 3-16.

5. McDonald SJ, Prendiville WJ, Blair E. Randomised controlled trial of oxytocin alone versus oxytocin and ergometrine in active management of third stage of labour. BMJ 1993; 307: 1167-71.

6. Longland PW, Rowbotham PC. Stability at room temperature of medicines normally recommended for cold storage. Pharm J 1987; 238: 147-150.

7. Jayasuriya DC. Pharmaceuticals and developing countries: problems and prospects. Pharm Weekbl [Sci. Ed.] 1991; 13: 244-247.

8. Bos CE. Tropical tablets. The development of tablet formulations for use in tropical countries. Thesis, Groningen, The Netherlands, 1990.

9. Walker GJA, Hogerzeil HV, Lindgren U. Potency of ergometrine in tropical countries. Lancet 1988; ii: 393.

10. Medisca. Letter to the WHO: Stability of injectable solutions containing the following uterotonic drugs as active principles "ergometrine"-"methylergometrine"-"oxytocin", 1989.

11. Hogerzeil HV, de Goeje MJ, Abu-Reid IO. Stability of essential drugs in Sudan. Lancet 1991; 338: 754-755.

12. Hogerzeil HV, Battersby A, Srdanovic V, Stjernstrom NE. Stability of essential drugs during shipment to the tropics. BMJ 1992; 304: 210-212.

13. Hogerzeil HV, Walker GJA, de Goeje MJ. Oxytocin more stable in tropical climates. BMJ 1994:308:59.

14. Anonymous. Ergot alkaloids and derivatives. In: Martindale. The extra pharmacopoeia. Reynolds JF (ed). The Pharmaceutical Press, London, 29th Ed. 1989. 1051-1059.

15. British Pharmacopoeia. Oxytocin tablets 1980; 799.

16. York P. The shelf life of some antibiotic preparations stored under tropical conditions. Pharmazie 1977; 32: 101-105.

17. Hartmann V, Krummen K, Schnabel G, Bethke H. Techniques of stability testing and shelf-life predictions. Pharm Ind 1982; 44: 71-79.

18. Halki JJ, Dayton OH, Ansbacker R et al. Obstetrics & Gynaecology: Ergonovine and methylergonovine. In: Heller WM et al. (eds). USP XXII. United States Pharmacopeia, 22nd revision, pp 512-54 & pp 871-873m. USP Convention, Inc, Rockville, 1990.

19. Protocol of the research of the stability of drugs in aqueous solutions: Dutch Society of Hospital Pharmacists, The Hague, The Netherlands, 1992.

20. Sondack DL, High-performance liquid chromatographic analysis of ergonovine maleate formulations. J Chrom 1978; 166: 615-618.

21. Tokunaga H, Kimura T, Kawamura J, Yamaha T. Stability of ergometrine maleate in aqueous solutions. Chem. Pharm. Bull, 1983; 31: 3988-3993.

22. De Groot ANJA, Vree TB, Hekster YA, van den Biggelaar-Martea M, van Dongen PWJ. High performance liquid chromatography of ergometrine and preliminary pharmacokinetics in plasma of men. J Chromatogr Biomed Appl, 1993; 613: 158-161.

23. Oxytocini solutio iniectabilis. Examination by liquid chromatography. Dutch Pharmacopoeia 9th ed. 1987; 519.1-519.7.

24. Rao PS, Weinstein GS, Wilson DW, et al. Isocratic high performance liquid chromatography-photodiode-array detection method for determination of lysine- and arginine-vasopressins and oxytocin in biological samples. J Chromatography 1991; 536: 137-42.

25. Maxl F, Siehr W. The use of high performance liquid chromatography in the quality control of oxytocin, vasopressin and synthetic analogues. J Pharm Biomed Anal 1989; 7: 211-216.

26. Koskinen EH, Kleimola T. Radioimmunoassay for ergotalkaloids in biological fluids. A Phys Scan 1976; suppl 440: 122.

27. Amico JA, Ulbrecht JS, Robinson AG. Clearance studies of oxytocin in humans using radioimmunoasasay measurements of the hormone in plasma and urine. J Clin Endocrinol Metab 1987; 64: 340-345.

28. Grimm W von. Stabilitätsprüfung pharmazeutischer Zubereitungen, Teil 2: Durchfürung von Langzeittests. Pharm Ind 1975; 37: 1075-1084.

29. Barends DM. Normen voor het gehalte van geneesmiddelen [Standards on drug content]. Pharm Weekbl 1990; 125: 956-958.

30. Van der Vaart FJ, Brenninkmeijer-de Groot FCMM, Tel H. Bereiding, op of onder de maat? [Manufacture, up to standard?] Pharm Weekbl 1990; 125: 953.

31. Del Pozo E, Brun del Re R, Hinselmann M. Lack of effect of methylergonovine on postpartum lactation. Am J Obstet Gynecol 1975; 123: 845-846.

32. Symes JB. A study on the effect of ergometrine on serum prolactin levels following delivery. J Obstet Gyn 1984; 5: 36-38.

33. Noriega-Guerra L, Aznar R, Arevalo N, Martinez-Zalce G, Martinez del Campo E, Lepe CM. Disadvantages of administration of oxytocin by oral absorption. Am J Obstet Gynecol 1966; 96: 849-856.

34. Obolensky W, Kupferschmied H. The latent period of buccal oxytocics. J Obstet Gynaec Brit Cwlth 1969; 76: 245-251.

35. Tobias H. Latent period, time to reach maximum effect, and disappearance of uterine contractility induced by desamino-oxytocin. Am J Obstet Gynecol 1975; 121: 337-341.

36. Dawood MY, Ylikorkala O, Fuchs F. Plasma oxytocin levels and disappearance rate after buccal Pitocin. Am J Obstet Gynecol 1980; 138: 20-24.

37. Thornton S, Davison JM, Baylis PH. Effect of human pregnancy on metabolic clearance rate of oxytocin. Am J Physiol, 1990; 259: R21-R24.

38. Connors KA, Amidon GL, Stella VJ. Chemical stability of pharmaceuticals. A handbook for pharmacists, 2nd ed. John Wiley and Sons, New York, 1986.

39. Van Dokkumburg AW. Stability of ergometrine injections. Groningen, The Netherlands. Wetenschapswinkel voor Geneesmiddelen, 1989.

40. De Groot ANJA, Vree TB, Hekster YA, van den Biggelaar-Martea M, van Dongen PWJ, van Roosmalen J. Pharmacokinetics and bioavailability of oral ergometrine in male volunteers. Biopharmaceutics & drug disposition 1994; 15: 65-73.

 

vers la section précédente
vers la section suivante
 
 
Le Portail d'information - Médicaments essentiels et produits de santé a été conçu et est maintenu par l'ONG Human Info. Dernière mise à jour: le 1 décembre 2019